Hepatitis D Virus and Hepatocellular Carcinoma

Hepatitis D virus (HDV) is a small, defective RNA virus that depends on hepatitis B virus (HBV) for virion assembly and transmission. It replicates within the nucleus of hepatocytes and interacts with several cellular proteins. Chronic hepatitis D is a severe and progressive disease, leading to cirr...

Full description

Bibliographic Details
Main Authors: Patrizia Farci, Grazia Anna Niro, Fausto Zamboni, Giacomo Diaz
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/5/830
_version_ 1797535306263560192
author Patrizia Farci
Grazia Anna Niro
Fausto Zamboni
Giacomo Diaz
author_facet Patrizia Farci
Grazia Anna Niro
Fausto Zamboni
Giacomo Diaz
author_sort Patrizia Farci
collection DOAJ
description Hepatitis D virus (HDV) is a small, defective RNA virus that depends on hepatitis B virus (HBV) for virion assembly and transmission. It replicates within the nucleus of hepatocytes and interacts with several cellular proteins. Chronic hepatitis D is a severe and progressive disease, leading to cirrhosis in up to 80% of cases. A high proportion of patients die of liver decompensation or hepatocellular carcinoma (HCC), but the lack of large prospective studies has made it difficult to precisely define the rate of these long-term complications. In particular, the question of whether HDV is an oncogenic virus has been a matter of debate. Studies conducted over the past decade provided evidence that HDV is associated with a significantly higher risk of developing HCC compared to HBV monoinfection. However, the mechanisms whereby HDV promotes liver cancer remain elusive. Recent data have demonstrated that the molecular profile of HCC-HDV is unique and distinct from that of HBV-HCC, with an enrichment of upregulated genes involved in cell-cycle/DNA replication, and DNA damage and repair, which point to genome instability as an important mechanism of HDV hepatocarcinogenesis. These data suggest that HBV and HDV promote carcinogenesis by distinct molecular mechanisms despite the obligatory dependence of HDV on HBV.
first_indexed 2024-03-10T11:42:35Z
format Article
id doaj.art-a25027616e74445fa9216f264592b49f
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T11:42:35Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a25027616e74445fa9216f264592b49f2023-11-21T18:21:13ZengMDPI AGViruses1999-49152021-05-0113583010.3390/v13050830Hepatitis D Virus and Hepatocellular CarcinomaPatrizia Farci0Grazia Anna Niro1Fausto Zamboni2Giacomo Diaz3Hepatic Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USAGastroenterology Unit, Fondazione IRCCS “Casa Sollievo Sofferenza”, San Giovanni Rotondo, 71013 Foggia, ItalyLiver Transplantation Center, Azienda Ospedaliera Brotzu, 09134 Cagliari, ItalyDipartimento di Scienze Biomediche, Università di Cagliari, 09124 Cagliari, ItalyHepatitis D virus (HDV) is a small, defective RNA virus that depends on hepatitis B virus (HBV) for virion assembly and transmission. It replicates within the nucleus of hepatocytes and interacts with several cellular proteins. Chronic hepatitis D is a severe and progressive disease, leading to cirrhosis in up to 80% of cases. A high proportion of patients die of liver decompensation or hepatocellular carcinoma (HCC), but the lack of large prospective studies has made it difficult to precisely define the rate of these long-term complications. In particular, the question of whether HDV is an oncogenic virus has been a matter of debate. Studies conducted over the past decade provided evidence that HDV is associated with a significantly higher risk of developing HCC compared to HBV monoinfection. However, the mechanisms whereby HDV promotes liver cancer remain elusive. Recent data have demonstrated that the molecular profile of HCC-HDV is unique and distinct from that of HBV-HCC, with an enrichment of upregulated genes involved in cell-cycle/DNA replication, and DNA damage and repair, which point to genome instability as an important mechanism of HDV hepatocarcinogenesis. These data suggest that HBV and HDV promote carcinogenesis by distinct molecular mechanisms despite the obligatory dependence of HDV on HBV.https://www.mdpi.com/1999-4915/13/5/830Hepatitis D viruscirrhosishepatocellular carcinomaHBV replicationHDV replicationtranscriptomics
spellingShingle Patrizia Farci
Grazia Anna Niro
Fausto Zamboni
Giacomo Diaz
Hepatitis D Virus and Hepatocellular Carcinoma
Viruses
Hepatitis D virus
cirrhosis
hepatocellular carcinoma
HBV replication
HDV replication
transcriptomics
title Hepatitis D Virus and Hepatocellular Carcinoma
title_full Hepatitis D Virus and Hepatocellular Carcinoma
title_fullStr Hepatitis D Virus and Hepatocellular Carcinoma
title_full_unstemmed Hepatitis D Virus and Hepatocellular Carcinoma
title_short Hepatitis D Virus and Hepatocellular Carcinoma
title_sort hepatitis d virus and hepatocellular carcinoma
topic Hepatitis D virus
cirrhosis
hepatocellular carcinoma
HBV replication
HDV replication
transcriptomics
url https://www.mdpi.com/1999-4915/13/5/830
work_keys_str_mv AT patriziafarci hepatitisdvirusandhepatocellularcarcinoma
AT graziaannaniro hepatitisdvirusandhepatocellularcarcinoma
AT faustozamboni hepatitisdvirusandhepatocellularcarcinoma
AT giacomodiaz hepatitisdvirusandhepatocellularcarcinoma